Researchers found that the global market for pharmaceutical suppositories is projected to grow from approximately $9.5 billion in 2024 to around $13.4 billion by 2034, at an annual growth rate of 3.5%. Suppositories are solid medications designed to be inserted into body cavities, such as the rectum or vagina, where they dissolve and release their active ingredients. They are particularly useful for individuals who cannot take medications orally due to conditions like vomiting or difficulty swallowing.

This growth is significant for people who want to manage health issues like constipation, hemorrhoids, or chronic pain, especially when oral medications are not an option. The increasing elderly population and the rising prevalence of gastrointestinal disorders are driving demand for these non-oral medication forms. Glycerin suppositories, in particular, are popular due to their effectiveness and safety, making them a go-to choice for over-the-counter laxatives.

The research highlights that while the market is expanding, barriers such as patient discomfort and social stigma related to the use of suppositories may limit their wider adoption. Current findings are based on market analysis rather than clinical trials, so while the growth projections are promising, they should be taken with caution. As the market evolves, innovations in formulation could improve patient comfort and acceptance, especially in pediatric and geriatric care.

Source: globenewswire.com